Education
About Us
Working with TipRanks
Follow Us
Hester Biosciences Limited (IN:HESTERBIO)
:HESTERBIO
Total Valuation
Hester Biosciences Limited has a market cap or net worth of ₹14.73B. The enterprise value is ―.
Market Cap₹14.73B
Enterprise Value―
Share Statistics
Hester Biosciences Limited has 8,506,865 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,506,865
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hester Biosciences Limited’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 5.50%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.50%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee4.85M
Profits Per Employee428.16K
Employee Count642
Asset Turnover0.48
Inventory Turnover1.46
Valuation Ratios
The current PE Ratio of Hester Biosciences Limited is 39.2. Hester Biosciences Limited’s PEG ratio is 0.96.
PE Ratio39.2
PS Ratio3.88
PB Ratio3.84
Price to Fair Value3.84
Price to FCF27.50
Price to Operating Cash Flow0.00
PEG Ratio0.96
Income Statement
In the last 12 months, Hester Biosciences Limited had revenue of 3.11B and earned 274.88M in profits. Earnings per share was 32.31.
Revenue3.11B
Gross Profit2.08B
Operating Income455.05M
Pretax Income395.71M
Net Income274.88M
EBITDA649.76M
Earnings Per Share (EPS)32.31
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Hester Biosciences Limited pays an annual dividend of ₹7, resulting in a dividend yield of 0.41%
Dividend Per Share₹7
Dividend Yield0.41%
Payout Ratio15.84%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.40
52-Week Price Change-22.21%
50-Day Moving Average1.94K
200-Day Moving Average1.84K
Relative Strength Index (RSI)32.03
Average Volume (3m)375.00
Important Dates
Hester Biosciences Limited upcoming earnings date is Nov 14, 2025, TBA (Confirmed).
Last Earnings DateAug 1, 2025
Next Earnings DateNov 14, 2025
Ex-Dividend DateAug 06, 2025
Financial Position
Hester Biosciences Limited as a current ratio of 1.56, with Debt / Equity ratio of 0.00%
Current Ratio1.56
Quick Ratio1.00
Debt to Market Cap0.17
Net Debt to EBITDA3.19
Interest Coverage Ratio3.58
Taxes
In the past 12 months, Hester Biosciences Limited has paid 107.45M in taxes.
Income Tax107.45M
Effective Tax Rate0.27
Enterprise Valuation
Hester Biosciences Limited EV to EBITDA ratio is 21.78, with an EV/FCF ratio of 32.22.
EV to Sales4.55
EV to EBITDA21.78
EV to Free Cash Flow32.22
EV to Operating Cash Flow21.93
Balance Sheet
Hester Biosciences Limited has ₹72.19M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹72.19M billion.
Cash & Marketable Securities₹72.19M
Total Debt₹0.00
Net Cash₹72.19M
Net Cash Per Share₹8.49
Tangible Book Value Per Share₹394.52
Margins
Gross margin is 59.80%, with operating margin of 14.63%, and net profit margin of 8.84%.
Gross Margin59.80%
Operating Margin14.63%
Pretax Margin12.72%
Net Profit Margin8.84%
EBITDA Margin20.89%
EBIT Margin15.48%
Analyst Forecast
The average price target for Hester Biosciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast4.68%
EPS Growth Forecast94.22%